Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsIndia

In charts | India’s COVID-19 case count, state-wise trends, vaccination data, and other key details

India reported 23,529 COVID-19 new cases, according to the September 30 update. Active infections down at 2.77 lakh mark; Over 65 lakh vaccine doses administered on Wednesday, with more than 88.34 crore doses administered till date.

September 30, 2021 / 11:01 AM IST
COVID-19 Testing

COVID-19 Testing

India’s COVID-19 case tally has breached 3.37 crore with 23,529 new cases reported, as per the health ministry’s September 30 update. As many as 311 new deaths were reported in the last 24 hours with 28,718 new recoveries in the same period, the latest release showed.

Sep 30 Daily New Cases and Moving Avg

Active covid cases in the country dropped by 5,000 to 277,020 in 24 hours, as per the September 30 update. Active cases dropped for the fourth consecutive day and was the lowest in 195 days. Kerala and Maharashtra accounted for nearly 67 percent of active cases in the country.

september-covid-update (4)_Sep 30

september-covid-update (3)_Sep 30

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

More than 88.34 crore vaccinations have been administered across India, according to the September 30 update, with 65,34,306 new vaccination doses administered on Wednesday.

Sep 30_BarLine_Daily New Vaccination Vs Daily New Cases

Of the total vaccinations administered to date, 73 percent are recipients of their first dose while 27 percent have received the second dose. Among states, Uttar Pradesh administered the most (cumulative) vaccine doses at 10.59 crore, followed by Maharashtra at 8.10 crore and Madhya Pradesh at 6.30 crore.

september-covid-update (5)_Sep 30

Globally, more than 23.40 crore COVID-19 cases have been recorded to date with over 47.88 lakh deaths. Active cases across the world at 1.83 crore as on date, with the US accounting for the most (53.6 percent); India (1.5 percent).
Moneycontrol News
first published: Sep 30, 2021 11:01 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark